142 related articles for article (PubMed ID: 23054402)
1. Predictors of outcome in stable outpatients with peripheral artery disease.
Sanclemente C; Yeste M; Suarez C; Coll R; Aguilar E; Sahuquillo JC; Lerma R; Monreal M;
Intern Emerg Med; 2014 Feb; 9(1):69-77. PubMed ID: 23054402
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.
Kaplovitch E; Eikelboom JW; Dyal L; Aboyans V; Abola MT; Verhamme P; Avezum A; Fox KAA; Berkowitz SD; Bangdiwala SI; Yusuf S; Anand SS
JAMA Cardiol; 2021 Jan; 6(1):21-29. PubMed ID: 32997098
[TBL] [Abstract][Full Text] [Related]
3. Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
Melgaard L; Gorst-Rasmussen A; Rasmussen LH; Lip GY; Larsen TB
PLoS One; 2016; 11(3):e0152269. PubMed ID: 27015524
[TBL] [Abstract][Full Text] [Related]
4. Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease.
Bernaudo D; Coll R; Sánchez Muñoz-Torrero JF; Pascual MT; García-Díaz AM; Alvarez LR; Monreal M;
Atherosclerosis; 2013 Jul; 229(1):258-62. PubMed ID: 23714334
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
[TBL] [Abstract][Full Text] [Related]
6. Alcohol consumption and outcome in stable outpatients with peripheral artery disease.
Garcia-Diaz AM; Marchena PJ; Toril J; Arnedo G; Muñoz-Torrero JF; Yeste M; Aguilar E; Monreal M;
J Vasc Surg; 2011 Oct; 54(4):1081-7. PubMed ID: 21684714
[TBL] [Abstract][Full Text] [Related]
7. Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
Altes P; Perez P; Esteban C; Sánchez Muñoz-Torrero JF; Aguilar E; García-Díaz AM; Álvarez LR; Jiménez PE; Sahuquillo JC; Monreal M;
Angiology; 2018 Jul; 69(6):507-512. PubMed ID: 29113452
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease.
Sanchez Muñoz-Torrero JF; Rico-Martín S; Álvarez LR; Aguilar E; Alcalá JN; Monreal M;
Atherosclerosis; 2018 Sep; 276():10-14. PubMed ID: 30006322
[TBL] [Abstract][Full Text] [Related]
9. Anemia and Outcome in Outpatients With Peripheral Artery Disease.
Perez P; Esteban C; Caballero PE; Muñoz-Torrero JF; Soria MT; Aguilar E; Rodríguez LR; Sahuquillo JC; Díaz AM; Monreal M;
Angiology; 2016 May; 67(5):484-9. PubMed ID: 26271128
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation.
Aguilar E; García-Díaz AM; Sánchez Muñoz-Torrero JF; Alvarez LR; Piedecausa M; Arnedo G; Monreal M;
Thromb Res; 2012 Sep; 130(3):390-5. PubMed ID: 22658293
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
Muñoz-Torrero JFS; Zamorano J; Rico-Martín S; Rivas MD; Bacaicoa MA; Robles R; Sanchez-Bacaicoa C; Monreal M;
Atherosclerosis; 2020 Jan; 292():84-89. PubMed ID: 31785493
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
[TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
Bonaca MP; Wiviott SD; Zelniker TA; Mosenzon O; Bhatt DL; Leiter LA; McGuire DK; Goodrich EL; De Mendonca Furtado RH; Wilding JPH; Cahn A; Gause-Nilsson IAM; Johanson P; Fredriksson M; Johansson PA; Langkilde AM; Raz I; Sabatine MS
Circulation; 2020 Aug; 142(8):734-747. PubMed ID: 32795086
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
16. High hemoglobin A
Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
[TBL] [Abstract][Full Text] [Related]
18. Cardiac rehabilitation and outcome in stable outpatients with recent myocardial infarction.
Coll-Fernández R; Coll R; Pascual T; Sánchez Muñoz-Torrero JF; Sahuquillo JC; Manzano L; Aguilar E; Alcala-Pedrajas JN; Alvarez LR; García-Díaz AM; Mujal A; Yeste M; Monreal M
Arch Phys Med Rehabil; 2014 Feb; 95(2):322-9. PubMed ID: 24121084
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
[TBL] [Abstract][Full Text] [Related]
20. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
